SCHEMBL27638755

SCHEMBL27638755

NC(=O)N(N)c1nc(N(N)C(N)=O)c2[nH]cnc2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.39
▸ PNP P00491 1/20 0.38
▸ PDPK1 O15530 2/20 0.38
▸ GDA Q9Y2T3 2/20 0.38
▸ MGMT P16455 2/20 0.37
▸ CYP1A2 P05177 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ CDK2 P24941 2/20 0.36
▸ CHEK1 O14757 1/20 0.36
▸ AURKA O14965 1/20 0.36
▸ CHEK2 O96017 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ HSP90AB1 P08238 1/20 0.36
▸ PRKACA P17612 1/20 0.36
▸ CCNE1 P24864 1/20 0.36
▸ MARK3 P27448 1/20 0.36
▸ RPS6KA3 P51812 1/20 0.36
▸ PRKCD Q05655 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30950289 0.73 PDPK1 (0.41) DPP4PNPPDPK1GDAMGMT
SCHEMBL31360537 0.63 CYP1A2 (0.35) DPP4PNPPDPK1GDAMGMT
SCHEMBL11078113 0.62 HTT (0.47) PDPK1GDAHSD17B10CDK2CHEK1
SCHEMBL15743207 0.61 DPP4 (0.62) DPP4PNPPDPK1GDACDK2
Guanine SCHEMBL29210198 0.60 PNP (0.84) DPP4PNPGDAHSD17B10ALDH1A1
SCHEMBL30544086 0.60 LRRK2 (0.67) PDPK1HSD17B10CDK2CHEK1AURKA
Guanine SCHEMBL8029348 0.59 PNP (0.81) DPP4PNPGDAHSD17B10ALDH1A1
SCHEMBL10405085 0.59 DPP4 (0.54) DPP4PNPPDPK1GDAMGMT
SCHEMBL6821773 0.59 PNP (0.45) DPP4PNPPDPK1GDAMGMT
SCHEMBL10629409 0.59 PNP (0.62) PNPGDAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102282155-B The synthetic method of the nucleic acid of phosphorus atoms modification 日本波涛生命科学公司 2017-06-09 — — CN claimed
CN-104163841-B For treating 2 ' and 3 '-nucleoside prodrugs of the modification of flaviviridae infections 埃迪尼克斯医药公司 2016-08-24 — — CN claimed
CN-107771218-A Plant regulating element and its application method 先锋国际良种公司 2018-03-06 — — CN disclosed
CN-107636165-A For nucleic acid library quality control and quantitative method, system and its composition 生命科技公司 2018-01-26 — — CN disclosed
CN-107109474-A Methods and compositions for nucleic acid detection 豪夫迈·罗氏有限公司 2017-08-29 — — CN disclosed
CN-107108565-A The N pyridine yl acetamide derivatives of the inhibitor of approach are transmitted as WNT signals 莱德克斯制药公共有限公司 2017-08-29 — — CN disclosed
CN-107072165-A Wheat Ms1 polynucleotides, polypeptides and methods of use 先锋国际良种公司 2017-08-18 — — CN disclosed
CN-106795157-A As the N pyridine yl acetamide derivatives of the inhibitor of Wnt signals transmission approach 莱德克斯制药公共有限公司 2017-05-31 — — CN disclosed
CN-106661616-A High throughput texture assay using nucleic acid calipers 儿童医学中心公司 2017-05-10 — — CN disclosed
CN-106460058-A Modified cytosine polynucleotide oligomers and methods 赛沛 2017-02-22 — — CN disclosed
CN-106459128-A Modified thymine polynucleotide oligomers and methods 赛沛 2017-02-22 — — CN disclosed
CN-106413836-A Surface modified filter media 霍林斯沃思和沃斯有限公司 2017-02-15 — — CN disclosed
CN-103620036-B Treatment of Frataxin (FXN) related diseases by inhibition of natural antisense transcript to FXN 库尔纳公司 2016-12-21 — — CN disclosed
CN-106170553-A Modified nucleic acid molecules and uses thereof 现代治疗公司 2016-11-30 — — CN disclosed
CN-105934438-A Nucleotides for the treatment of liver cancer 艾登尼克斯药业有限公司 2016-09-07 — — CN disclosed
CN-105874072-A Artificial nucleic acid molecules 库瑞瓦格股份公司 2016-08-17 — — CN disclosed
CN-105792832-A Organic compounds to treat hepatitis b virus 诺华股份有限公司 2016-07-20 — — CN disclosed
CN-1816558-A Modified fluorinated nucleoside analogues PHARMASSET LTD (US) 2006-08-09 — — CN disclosed
Send feedback